Thu, May 28, 2020
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Systematica to launch new UCITS- compliant fund for UK and European Investors

Monday, November 13, 2017
Opalesque Industry Update - Systematica Investments [Systematica], the technology-driven manager focused on a quantitative and systematic investment approach, has extended its portfolio offering to a broader investor base through the launch of a new UCITS fund based on the Systematica Alternative Risk Premia (SARP) strategy.

Since its launch on 1 March 2017, SARP has seen strong investor interest, growing assets under management to $120 million. A UCITs version of the SARP strategy will be made available to UK and European investors and their advisers on 8 November 2017, with a commitment to invest from a significant seed investor of $122 million. The fund will have daily liquidity and will be Systematica's second strategy on its Dublin based UCITS Fund ICAV platform.

The SARP approach was developed as part of Systematica's strategy to further diversify its product range and to meet investor demand for higher capacity, lower fee products that provide differentiated returns with greater transparency, liquidity and cost focus than traditional hedge fund products.

SARP utilizes "alternative risk premia" such as value, momentum, carry and defensive characteristics, which have been shown to demonstrate well established sources of return. Using stocks and futures, SARP allocates investments across a broad range of strategies and asset classes to maximize fund diversification whilst taking account of trading costs and liquidity. The strategy targets an annualised volatility of 8-10% and net returns of 6-8% over a market cycle.

Leda Braga, Chief Executive Officer, Systematica Investments, comments: "I am pleased that a broader segment of investors will now be able to access our innovative SARP strategy. This systematic trading programme provides investors with high quality implementation of well documented alternative risk premia strategies across global markets."

"Within the class of hedge fund strategies, it is well known that systematic strategies (especially systematic macro strategies) provide attractive diversification benefits to global equity markets. SARP demonstrates strong diversification benefits, and is largely uncorrelated to a composite hedge fund portfolio as well."

Managed through Systematica's team based approach, the fund will be overseen by Product Manager Matthias Hagmann, who has been at Systematica since its formation.

As of November 8th, the shares in the fund will be available in US dollars, euros, Swiss francs, sterling, Australian dollars, Hong Kong dollars, Yen and Singapore dollars. It will be registered for marketing in various EU jurisdictions, including the UK, Netherlands, Italy, Luxembourg, Spain and Greece. Following the launch, an application for passporting will also be made in Switzerland, Australia and Singapore, with more expected to follow. The fund will be regulated as a UCITS product by the Central Bank of Ireland.

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Tiger Global tops the list US-based venture capital market[more]

    Laxman Pai, Opalesque Asia: Tiger Global Management holds on to its position as market-leader in US-based venture capital, said a study. According to Preqin, the closure of tech-focused Tiger Global Private Investment Partners XII in January means the New York-based firm has raised more than

  2. Tech: Fintech startup Brex closes $150m in pure venture funding amid recession[more]

    From Business Insider: Brex, the 3-year-old fintech unicorn, raised an additional $150 million in equity funding from existing investors and Lone Pine Capital, the company announced Tuesday. The cash infusion raised the startup's valuation to "around the $3 billion mark," cofounder and co-CEO Henriq

  3. PE/VC: Venture debt set to take prominent role, Building out Goldman Sachs's private-equity business[more]

    Venture debt set to take prominent role From PE News: Venture debt financing could be having its moment as the equity market becomes less friendly to start-ups. About $10bn worth of venture debt deals were made this year as of 21 April, a pace set to eclipse the roughly $25bn in such de

  4. Study: Emerging market bond issuers take hit as global recession deepens, The coronavirus pandemic could cost the global economy a nightmarish $82tn over 5 years, a Cambridge study warns[more]

    Emerging market bond issuers take hit as global recession deepens Increasing credit stress evident amongst many high-yield EM non-financial corporates as coronavirus disruption takes its toll, says Moody's. 74 out of 106 rated EM sovereigns have a stable outlook as of 30 April 2020 (compa

  5. Investing: Singer bets on Europe, emerging markets, Britain's unhealthy appetite for financial risk in essential services, How Stan Druckenmiller shook up his portfolio[more]

    Singer bets on Europe, emerging markets From Investment Magazine: William Blair's Brian Singer is looking to invest in Europe and the emerging markets as the recovery from the global economic shutdown to contain the pandemic will likely take longer than what the market has priced in.